Navigation Links
Accuray Reports Financial Results for First Quarter of Fiscal Year 2014
Date:11/7/2013

$  40,628Services 

47,07342,120Total net revenue 

76,64182,748Cost of revenue:Cost of products 

18,60124,009Cost of services 

31,56235,063Total cost of revenue 

50,16359,072Gross profit 

26,47823,676Operating expenses:Selling and marketing 

14,45412,889Research and development 

12,95018,574General and administrative 

11,36012,842Total operating expenses 

38,76444,305Loss from operations

(12,286)(20,629)Other expense, net

(2,460)(704)Loss before provision for income taxes

(14,746)(21,333)Provision for income taxes

787597Loss from continuing operations

(15,533)(21,930)Loss from discontinued operations attributable to stockholders

-(2,200)Net loss attributable to stockholders

$(15,533)$(24,130)Loss per share attributable to stockholdersBasic and diluted - continuing operations

$
(0.21)$
(0.31)Basic and diluted - discontinued operations

$
-$
(0.03)Basic and diluted - net loss

$
(0.21)$
(0.34)Weighted average common shares used in computing loss per shareBasic and diluted

74,70071,995  Accuray Incorporated  Consolidated Balance Sheets  (in thousands)  (Unaudited)  September 30,  June 30, 20132013 Assets  Current assets:  Cash, cash equivalents and investments 

$
,595

$
74,397 Restricted cash 

2,783

2,728 Accounts receivable, net of allowance for doubtful accounts 

60,136

55,458 Inventories 

87,989

81,592 Prepaid expenses and other current assets 

13,083

12,595 Deferred cost of revenue 

8,658

9,165Total current assets 

334,244

335,935
'/>"/>

SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip
2. Accuray Announces First CyberKnife System in South America
3. Accuray Surpasses 600 Installations Globally
4. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
5. Omeros Corporation Reports Third Quarter 2013 Financial Results
6. Global Positron Emission Tomography Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
7. Global In Vitro Fertilization Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
8. Global Biophotonics Market & OSS BSS Industry 2012-2016 Reports
9. China Vanadium Catalyst Market for Sulfuric Acid Production in A New Research Available at MarketReportsChina.com
10. Cytos Biotechnology Ltd Reports Third Quarter 2013 Financial Results and Recent Developments
11. Neurocrine Biosciences Reports Third Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015  In recognition of World Hemophilia ... hemophilia advocacy groups to illuminate more than 15 prominent landmarks ... Boston,s Zakim Bridge and Prudential Tower, ... Orleans, Mercedes-Benz Superdome and Denver,s ... the evening of April 17, and coincide with hemophilia community ...
(Date:4/16/2015)... , April 16, 2015 /CNW/ - Bioenterprise Corporation is ... newest office in Charlottetown , PEI.  ... Prince Edward Island ADAPT Council for the commercialization of ... forward to working with PEI ADAPT.  They have been ... more than a decade," explains Dave Smardon , ...
(Date:4/16/2015)... DIEGO , April 16, 2015  AnaptysBio, ... development of therapeutic antibodies, today announced the ... antibody program into IND-enabling studies. The Company,s ... novel treatment for generalized pustular psoriasis (GPP), ... unmet medical need. ANB019 is wholly owned within ...
(Date:4/16/2015)... , April 16, 2015  EMD Serono today ... Darmstadt, Germany , appointed ... Head of Global Clinical Development.  Dr. Reicin brings ... experience in Oncology and Immunology. She is an ... served as a Vice President in various capacities ...
Breaking Biology Technology:Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4Bioenterprise Corporation Expands into the Maritimes 2AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 3
... Jan. 5 RainDance Technologies, Inc., a,provider of innovative ... that it has been selected to share in the,first-ever ... Center (MLSC). , The MLSC ... years to Dr. David,Weitz, Mallinckrodt Professor of Physics and ...
... DEERFIELD, Ill. and SAN DIEGO, Jan. 5 ... HALO ) today,announced the start of a ... Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in ... (rHuPH20,Enhanze(TM) Technology) for the treatment of primary immunodeficiency ...
... Singapore investigators to coordinate 700 patient trial of ... of head and neck cancer,MISSISSAUGA, ON, Jan. 5 ... TSX:YM, AIM:YMBA), an oncology company that identifies, develops ... announced that the National Cancer Centre of Singapore ...
Cached Biology Technology:RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants 2RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants 3RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants 4Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 2Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 3Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 4Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 5YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 2YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 3YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 4
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... 2, 2015 Fingerprint Cards (FPC) ... FPC1025 from the distributor World Peace Industrial Group (WPI), ... 2015 although the major part of the shipments will ... used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... how an enzyme repairs DNA. Enzymes called helicases ... Maria Spies, a University of Illinois biochemistry professor. ... machineries orchestrating DNA repair in the cell. she said. ... malfunctions in these enzymes. Spies laboratory undertook a ...
... Povich of the yellow jacket world. In his laboratory, ... family dynamics within a colony. Even though only one ... mates with several males, creating a complex family tree. ... described as one of the greatest achievements of evolution ...
... is available in French . , Imagine a ... of CO 2 the equivalent of 2.2 days ... measuring up to 100 metres in radius and several kilometres ... below the oceans surface. At first blush, this might ...
Cached Biology News:Researchers probe a DNA repair enzyme 2Research uncovers the social dynamics of yellow jackets 2Research uncovers the social dynamics of yellow jackets 3Research uncovers the social dynamics of yellow jackets 4Into the abyss: Deep-sixing carbon 2
BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....
... designed for sequencing inserts cloned into M13/pUC-based ... T3 RNA polymerase promoters, or lambda gt10 ... a concentration of 0.1 µg/µl in water. ... sequencing reactions using SequiTherm™ EXCEL™ II DNA ...
BD BioCoat Collagen I 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I....
Topoisomerase II...
Biology Products: